Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While studies conducted in other countries have...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kim, Soon Ae, Shim, Woo Ho, Lee, Eun Hae, Lee, Young Mi, Beom, Sun Hee, Kim, Eun Sook, Yoo, Jeong Seon, Nam, Ji Sun, Cho, Min Ho, Park, Jong Suk, Ahn, Chul Woo, Kim, Kyung Rae
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Diabetes Association 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122893/
https://ncbi.nlm.nih.gov/pubmed/21738898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.159
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia